INNOSTIC (Stock Code: 301584) and Inovance Automotive (Stock Code: 301656) will land on ChiNext board on September 25, 2025.

INNOSTIC is publicly offering 63.193277 million shares, including 63.193277 million IPO shares offered at 7.05 yuan per share and raising funds of 446 million yuan. The post-public-offering share capital of INNOSTIC is 421.288509 million shares in total. Shanghai C and D INNOSTIC Medical Technology Group Co., Ltd. principally engages in the direct sale, distribution of medical devices and centralized management of hospital consumables (SPD) business. In 2024, its operating income reached 17.923 billion yuan with the net profit of 228.3116 million yuan.

Inovance Automotive is publicly offering 288.57491 million shares, including 288.57491 million IPO shares offered at 12.48 yuan per share and raising funds of 3.601 billion yuan. The post-public-offering share capital of Inovance Automotive is 2.40479091 billion shares in total. Suzhou Inovance Automotive Co., Ltd. principally engages in the research and development, production, sale and service of core components of power systems such as electric drive systems and power supply systems for new energy vehicles. In 2024, its operating income reached 16.178 billion yuan with the net profit of 935.9105 million yuan.